Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?


    loading  Checking for direct PDF access through Ovid

Abstract

Secondary hyperparathyroidism may develop in the presence of hypovitaminosis D in order to maintain calcium homeostasis. We conducted a cross-sectional analysis in a cohort of 371 patients, identifying secondary hyperparathyroidism in 65 patients. This high prevalence (17.5%) was in part justified by the high prevalence of hypovitaminosis D (77.4%) in the whole sample, but we also identified an independent association with the use of tenofovir.

    loading  Loading Related Articles